MIrabegron With oveRACtive bLadder Symptoms in mEn

NCT02361502 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

462

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: mirabegron
DRUG: placebo

Sponsor

Seoul National University Hospital